Saturday 17 October 2026
Export SERA’s income statement to Excel — free account
Sera Prognostics, Inc.
SERA Healthcare Medical Devices
Sera Prognostics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $81,000.00, up 5.19% from fiscal 2024. In the quarter to June 2026, revenue grew 76.5%, EPS fell 12.5% and free cash flow fell 10.6%, each against the same quarter a year earlier.
2.06
0.03
+1.48%
Follow SERA
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
3 | 3 | — | 3 |
| (47.69%) | (51.83%) | (39.58%) | (45.03%) | ||
| (34.87%) | (36.59%) | (30.36%) | (33.47%) | ||
ROIC |
(59.44%) | (63.01%) | (113.18%) | (180.22%) | |
Return on Tangible Assets |
(148.15%) | (180.07%) | (117.29%) | (131.88%) | |
Average Days of Receivables |
53.79 | 54.07 | 70.44 | 52.14 | |
Free Cash Flow per Share |
(0.53) | (0.55) | (0.55) | (0.57) | |
Free Cash Flow |
(26.17) | (26.35) | (27.57) | (28.53) | |
Capital Expenditures |
(0.40) | (0.73) | (0.73) | (0.85) | |
| Other line items | |||||
Cash ROIC |
(20.85%) | (22.99%) | (23.97%) | (26.96%) | |
Accounts Receivable Turnover |
2.04 | 3.52 | 3.17 | 5.19 | |
Accounts Payable Turnover |
0.13 | 0.12 | 0.17 | 0.16 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
2,457.82 | 1,918.48 | 1,686.48 | 2,482.00 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
13,783.16% | 16,260.49% | 22,573.68% | 18,604.29% | |
Selling, General and Administrative Expense of Revenue |
25,073.68% | 28,703.70% | 41,470.18% | 34,528.57% | |
Share Based Compensation of Revenue |
6,008.42% | 6,308.64% | 7,810.53% | 5,615.71% | |
Interest Coverage |
(2,640.93) | (4,056.00) | (5,230.57) | (5,328.29) | |
Operating CF/Net income |
0.79 | 0.80 | 0.84 | 0.83 | |
Depreciation/Fixed assets |
0.88 | 0.82 | 0.84 | 0.61 | |
Capex/Depreciation |
(0.45) | (0.77) | (0.80) | (0.98) | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.52) | (0.54) | (0.53) | (0.55) | |
Capex per Share |
(0.01) | (0.02) | (0.01) | (0.02) | |
Capex to Sales |
4.25 | 8.96 | 12.82 | 12.14 |
Columns are period end dates